A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833

Trial Identifier: D8532C00005
Sponsor: AstraZeneca
Collaborator:
Quotient Sciences Ltd
NCTID:: NCT05364255
Start Date: May 2022
Primary Completion Date: June 2022
Study Completion Date: June 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
English (UK) Translation

Trial Locations

Country Location
GB Ruddington, GB, NG11 6JS